Overview
Union Bank is a private commercial bank serving retail, SME and corporate customers through branches and digital channels. The June quarter marked a material improvement in operating profitability, while the proposed rights issue would add capital for lending growth if approved and completed.
The assessment moves bullish from a fairly valued market-wide starting band because the latest comparable June operating and net margins were both the bank's strongest on record, rather than merely a result of a low prior-year base.
Price performance
At LKR 11.80 on 16 September 2026, the share had fallen 9.9% over three months, versus a 5.6% fall in the ASPI. It was near its 52-week low, and both recent volatility and trading volume were below the bank's own one-year and 60-day norms.
The record since September 2023 is three falls of 15% or more in three years, the deepest 36%, which has not yet recovered. Median daily turnover was LKR 313,138 over 60 sessions; a LKR 1 million order is more than everything that trades on a typical day, making that order a large part of normal trading.
Valuation
The P/E is 19.7 times, meaning the price pays LKR 19.70 for each rupee of trailing profit, and it ranks at the 88th percentile of banking and finance peers. That is a demanding earnings valuation relative to the sector, despite the recent improvement in profit.
The P/B is 0.62 times, or 62 cents for each rupee of net assets, and is at the 21st sector percentile. The latest audited return on equity was 3.2%, so the discount to book is consistent with a modest return generated on shareholders' funds. It is cheaper than 74% of days since February 2012 on P/B. No dividend is on record in the last two years, leaving no cash yield to offset the earnings multiple.
News and sentiment
Coverage was about normal for the bank, with 10 material articles over 90 days: six positive and four neutral. Results reported on 31 July included LKR 587 million of first-half PAT, up 134% year-on-year, but also LKR 249 million from the sale of UB Finance shares, which is not recurring banking income.
The rights issue was declared on 31 August at one new share for every 16 held, at LKR 10.46 per share. It remains announced rather than confirmed, with approvals still required.
Financials
June-quarter revenue rose 10.8% year-on-year to LKR 2.7 billion, while net profit rose 136.2% to LKR 481 million. Profit therefore grew far faster than income, reflecting a much more profitable quarter rather than balance-sheet expansion alone.
Gross margin is not applicable in the supplied bank data. Operating margin widened from 24.6% to 35.5%, while net margin rose from 8.3% to 17.8%; both were the best of eight comparable June quarters. The LKR 480 million gap between operating and net profit shows that tax, finance costs and other below-operating items still absorbed roughly half of operating profit.
The latest audited year ended December 2025, not the current quarter, recorded ROE of 3.2%. Equity had risen to LKR 21.1 billion by June, while profit attributable to minority shareholders was LKR 9 million, too small to materially separate group profit from the profit attributable to the listed shares.
Risks
The largest business risk is the reliance of the first-half profit improvement on non-recurring gains: the LKR 249 million UB Finance share sale reported on 31 July was material against reported first-half PAT of LKR 587 million. The June-quarter margin record is strong, but the underlying banking earnings picture cannot be isolated fully from that disposal in the reported half-year result.
For a lender, liabilities relative to equity are the relevant leverage measure. This ratio rose to 7.93 times at December 2025 from 6.7 times a year earlier, meaning deposits and other liabilities are a much larger funding base than shareholder capital. Sector conditions also carry funding, treasury-book and foreign-exchange sensitivity as bond yields have risen and the rupee has weakened.
The pending 1:16 rights issue would increase the share count if completed. Its terms were announced on 31 August, but the event has no ex-date and the supplied structured-event data does not permit dilution arithmetic.
Outlook
As at 16 September 2026, the next company-specific evidence is the September interim quarter, expected to be filed between 6 and 14 November. It will supersede the June figures and show whether the higher operating profitability continued after the reported UB Finance disposal gain.
The proposed rights issue is also unresolved, with its ex-date expected between 25 September and 19 December if the process proceeds. Its stated purpose is stronger Tier 1 capital and loan-book expansion, but this data cannot establish the eventual approval outcome, timing or earnings contribution.